These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 731408)

  • 1. Rate of phenytoin accumulation in man: a simulation study.
    Ludden TM; Allen JP; Schneider LW; Stavchansky SA
    J Pharmacokinet Biopharm; 1978 Oct; 6(5):399-415. PubMed ID: 731408
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a nomogram for estimating the rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):166-70. PubMed ID: 3617155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of sucralfate upon phenytoin absorption in man.
    Smart HL; Somerville KW; Williams J; Richens A; Langman MJ
    Br J Clin Pharmacol; 1985 Sep; 20(3):238-40. PubMed ID: 3840029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of food on the absorption of phenytoin in man.
    Melander A; Brante G; Johansson O; Lindberg T; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1979 May; 15(4):269-74. PubMed ID: 477711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability and single-dose pharmacokinetics of intramuscular phenytoin.
    Kostenbauder HB; Rapp RP; McGovren JP; Foster TS; Perrier DG; Blacker HM; Hulon WC; Kinkel AW
    Clin Pharmacol Ther; 1975 Oct; 18(4):449-56. PubMed ID: 1100308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and phenytoin kinetics in adult epileptics.
    Bauer LA; Blouin RA
    Clin Pharmacol Ther; 1982 Mar; 31(3):301-4. PubMed ID: 7060313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interindividual variation in the extent and rate of phenytoin accumulation.
    Levine M; Orr J; Chang T
    Ther Drug Monit; 1987 Jun; 9(2):171-6. PubMed ID: 3617156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite effects of carbohydrate and protein on phenytoin absorption in man.
    Johansson O; Wahlin-Boll E; Lindberg T; Melander A
    Drug Nutr Interact; 1983; 2(2):139-44. PubMed ID: 6678751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The elimination of phenytoin in man.
    Eadie MJ; Tyrer JH; Bochner F; Hooper WD
    Clin Exp Pharmacol Physiol; 1976; 3(3):217-24. PubMed ID: 975617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dietary protein and carbohydrate on phenytoin metabolism in man.
    Balabaud C; Vinon G; Paccalin J
    Br J Clin Pharmacol; 1979 Oct; 8(4):369-71. PubMed ID: 508512
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics of diphenylhydantoin disposition in man.
    Suzuki T; Saito Y; Nishihara K
    Chem Pharm Bull (Tokyo); 1970 Feb; 18(2):405-11. PubMed ID: 5438584
    [No Abstract]   [Full Text] [Related]  

  • 12. Reduction of phenytoin clearance caused by cimetidine.
    Frigo GM; Lecchini S; Caravaggi M; Gatti G; Tonini M; D'Angelo L; Perucca E; Crema A
    Eur J Clin Pharmacol; 1983; 25(1):135-7. PubMed ID: 6617717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of placentally transferred phenytoin and its p-hydroxylated metabolites in newborn infants.
    Rane A; Hoppel C; Höjer B
    Br J Clin Pharmacol; 1979 Nov; 8(5):465-8. PubMed ID: 508552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin clearance by continuous ambulatory peritoneal dialysis.
    Hays DP; Primack WA; Abroms IF
    Drug Intell Clin Pharm; 1985 Jun; 19(6):429-31. PubMed ID: 4006737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin kinetics in children.
    Curless RG; Walson PD; Carter DE
    Neurology; 1976 Aug; 26(8):715-20. PubMed ID: 945868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A theoretical and an in vitro experimental model for estimation of drug transfer through the human placenta.
    Mor L; Bental E; Lightman A; Shachar H; Mor LA; Urbach J; Sideman S; Brandes JM
    Contrib Gynecol Obstet; 1985; 13():155-7. PubMed ID: 3995976
    [No Abstract]   [Full Text] [Related]  

  • 17. The bioavailability of phenytoin.
    Gugler R; Fröscher W; Eichelbaum M; Hildenbrand G
    J Neurol; 1977 Oct; 216(3):155-62. PubMed ID: 72133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with NONMEM: analysis of routine phenytoin clinical pharmacokinetic data.
    Sheiner LB; Grasela TH
    Drug Metab Rev; 1984; 15(1-2):293-303. PubMed ID: 6547663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle size distribution affects the human bioavailability of phenytoin.
    Yakou S; Yamazaki S; Sonobe T; Sugihara M; Fukumuro K; Nagai T
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4400-2. PubMed ID: 3829172
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of folic acid on phenytoin kinetics in healthy subjects.
    Furlanut M; Benetello P; Avogaro A; Dainese R
    Clin Pharmacol Ther; 1978 Sep; 24(3):294-7. PubMed ID: 688723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.